DAVID PRAGER, M.D., F.A.C.P.; JOHN RULE, M.D.; HARRY KINTZI, M.D.
To the editor: I am writing with regard to the comments made by Dr. Yeung and Dr. Trowbridge (1) on hypokalemia in the blastic crisis of chronic granulocytic leukemia.
At present we have a 38-year-old male patient in the blastic phase of chronic myelogenous leukemia who has a persistent hypokalemia. The serum potassium usually ranges around 2.5 meq./litre. There is no significant difference between the serum and plasma potassium levels. The patient has not received any antibiotics. Therefore, this case lends further support to the statements by Drs. Yeung and Trowbridge that the hypokalemia, which has been associated with
PRAGER D, RULE J, KINTZI H. Hypokalemia in Leukemia. Ann Intern Med. ;86:118. doi: 10.7326/0003-4819-86-1-118_1
Download citation file:
Published: Ann Intern Med. 1977;86(1):118.
Endocrine and Metabolism, Fluid and Electrolyte Disorders, Nephrology.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use